title: Do we know when to treat neonatal thrombocytopaenia?
authors.affiliation: Neonatal Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, UK.
authors.forename: Vidheya
authors.initials: V
authors.lastname: Venkatesh
authors.forename: Anna E
authors.initials: AE
authors.lastname: Curley
authors.forename: Paul
authors.initials: P
authors.lastname: Clarke
authors.forename: Timothy
authors.initials: T
authors.lastname: Watts
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Stanworth
mesh_terms: D002543:Cerebral Hemorrhage / Q000209:etiology; D015897:Comorbidity; D000075202:Contraindications; D017408:Guidelines as Topic; D006801:Humans; D007231:Infant, Newborn; D010976:Platelet Count; D017713:Platelet Transfusion / Q000009:adverse effects*; D053628:Receptors, Thrombopoietin / Q000819:agonists / Q000627:therapeutic use; D012306:Risk; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000097:blood / Q000628:therapy*
chemical_list: D053628:Receptors, Thrombopoietin
keywords: Neonatology; intraventricular haemorrhage; platelet transfusion; thrombocytopenia